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Rochester, Minnesota
Objectives The purpose of this study was to determine the lifetime burden and risk factors for hospitalization after heart
failure (HF) diagnosis in the community.
Background Hospitalizations in patients with HF represent a major public health problem; however, the cumulative burden of hos-
pitalizations after HF diagnosis is unknown, and no consistent risk factors for hospitalization have been identified.
Methods We validated a random sample of all incident HF cases in Olmsted County, Minnesota, from 1987 to 2006 and
evaluated all hospitalizations after HF diagnosis through 2007. International Classification of Diseases-9th Revi-
sion codes were used to determine the primary reason for hospitalization. To account for repeated events,
Andersen-Gill models were used to determine the predictors of hospitalization after HF diagnosis. Patients were
censored at death or last follow-up.
Results Among 1,077 HF patients (mean age 76.8 years, 582 [54.0%] female), 4,359 hospitalizations occurred over a
mean follow-up of 4.7 years. Hospitalizations were common after HF diagnosis, with 895 (83.1%) patients hospi-
talized at least once, and 721 (66.9%), 577 (53.6%), and 459 (42.6%) hospitalized 2, 3, and 4 times, re-
spectively. The reason for hospitalization was HF in 713 (16.5%) hospitalizations and other cardiovascular in
936 (21.6%), whereas over one-half (n  2,679, 61.9%) were noncardiovascular. Male sex, diabetes mellitus,
chronic obstructive pulmonary disease, anemia, and creatinine clearance 30 ml/min were independent predic-
tors of hospitalization (p  0.05 for each).
Conclusions Multiple hospitalizations are common after HF diagnosis, though less than one-half are due to cardiovascular
causes. Comorbid conditions are strongly associated with hospitalizations, and this information could be used to
define effective interventions to prevent hospitalizations in HF patients. (J Am Coll Cardiol 2009;54:1695–702)
© 2009 by the American College of Cardiology Foundation
ublished by Elsevier Inc. doi:10.1016/j.jacc.2009.08.019l
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mn estimated 5.3 million Americans are living with heart
ailure (HF), and its prevalence has risen (1). Although
mprovements in mortality after HF diagnosis have been
oted (2,3), hospitalizations related to HF have increased
rom an estimated 400,000 discharges in 1979 to nearly 1.1
illion in 2005 (1). With growing numbers of patients
iving with HF and increasing hospitalizations, HF costs are
ignificant, with 2008 U.S. estimated costs of $34.8 billion
1). Thus, HF constitutes a major public health problem, a
rom the *Division of Cardiovascular Diseases and †Department of Health Sciences
esearch, Mayo Clinic, Rochester, Minnesota. This study was funded by a National
nstitutes of Health RO1 Grant (HL72435) to Dr. Roger, an American Heart
ssociation Postdoctoral Fellowship Award to Dr. Dunlay, and a National Institutes
f Health Ruth L. Kirschstein National Research Service Award (T32 HL07111-
1A1) to Dr. Dunlay and was made possible by the Rochester Epidemiology Project
Grant #R01-AR30582 from the National Institute of Arthritis and Musculoskeletal
nd Skin Diseases).H
Manuscript received May 6, 2009; revised manuscript received August 25, 2009,
ccepted August 30, 2009.arge component of which is related to hospitalizations. Yet,
ittle is known about the natural history of hospitalizations
fter diagnosis of HF. Further, data on the cause of
ospitalization after HF diagnosis are sparse. Finally, it has
een recently underscored that no consistent predictors of
ospitalization in patients with HF have emerged, which
inders the development of effective interventions (4).
See page 1703
Although important knowledge has been gained from pa-
ients enrolled in HF clinical trials and from databases com-
rised of patients hospitalized with HF, these studies cannot
ully appraise the total burden of hospitalization in patients
ith HF. Indeed, patients enrolled in clinical trials differ from
he community because they are younger, more frequently
ale, and have low ejection fraction (EF) (5). Further, large
F registries and databases focus only on patients who have
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compensated HF (6–8) who may
not represent the community, as
hospitalization for HF has been
shown to be a poor prognostic sign
(9,10), and these patients may be
at higher risk for subsequent HF
hospitalizations (11). Finally, the
use of prevalent cases and analysis
of only short-term rehospitaliza-
tion prevents examination of the
cumulative lifetime burden of hos-
pitalizations in patients after initial
HF diagnosis.
To address these gaps in knowledge, we undertook the
resent study of incident HF cases diagnosed from 1987
hrough 2006 in a stable community setting to examine the
requency and causes of all hospitalizations that occurred over
he course of a lifetime after HF diagnosis and whether
hanges have occurred over time. Second, we determined the
isk factors for hospitalization after HF diagnosis.
ethods
tudy design and setting. This study was conducted in
lmsted County, Minnesota, which has an estimated 2006
opulation of 137,521, 90% of whom are Caucasian.
opulation-based research is possible because there are few
ealth care providers; the largest is Mayo Clinic. Medical
ecords from all sources of care for residents are extensively
ndexed and linked via the Rochester Epidemiology Project
12). Herein, all patient-level information was obtained via
he medical and administrative records. Patients were ex-
luded from analysis if they declined to provide Minnesota
esearch Authorization. Studies were approved by the
ayo Clinic and Olmsted Medical Center institutional
eview boards.
atient identification. Olmsted County residents with a
ossible HF diagnosis were identified using International
lassification of Diseases-9th Revision (ICD-9) code 428
HF). Codes are assigned based on physician diagnoses
uring outpatient visits or at hospital discharge. From all
atients with ICD-9 code 428, a subset was randomly
elected to undergo case validation and data abstraction.
he HF index date was defined as the first evidence of HF
n the medical record. Patients diagnosed with HF prior to
he study period were excluded. Cases were validated using
ethods previously described (2). Abstractors reviewed
ecords to ensure the HF episode met Framingham criteria.
hen utilized previously, missing data were minimal, and
ramingham criteria could be applied in 98% of cases. The
nterabstractor agreement was 100%, indicating that these
ethods are highly reproducible.
atient-level data. Baseline characteristics were abstracted
rom the medical record. Physician’s diagnosis was used to
Abbreviations
and Acronyms
CI  confidence interval
COPD  chronic
obstructive pulmonary
disease
EF  ejection fraction
HF  heart failure
HR  hazard ratio
ICD-9  International
Classification of Diseases-
9th Revisionefine hyperlipidemia, chronic obstructive pulmonary dis- tase (COPD), cerebrovascular disease, and peripheral vas-
ular disease. Smoking status was classified as “current” or
prior/never.” Hypertension was defined by physician diag-
osis, systolic blood pressure 140 mm Hg, or diastolic
lood pressure 90 mm Hg. Diabetes mellitus was defined
y blood glucose levels based on year-specific National
iabetes Data Group criteria (glucose 140 mg/dl since
ay 1972, 120 mg/dl from December 1958 to April
972, and 130 mg/dl before December 1958) or use of
iabetic medications. Prior myocardial infarction was de-
ned using validated criteria (13). Body mass index was
alculated using weight and height at HF diagnosis. The
harlson Index, a comorbidity score, was calculated (14).
Hemoglobin, creatinine, and EF at HF diagnosis (within
year) were abstracted. Anemia was defined as hemoglobin
13 mg/dl in men or 12 mg/dl in women (15). Creati-
ine clearance was estimated using the Modification of Diet
n Renal Disease equation (16).
tudy outcomes. Data on all-cause hospitalizations occur-
ing after HF diagnosis from 1987 through 2007 were
btained through the Olmsted County Healthcare Expen-
iture and Utilization Database, which contains informa-
ion regarding Olmsted County hospitalizations since 1987.
or patients hospitalized at initial HF diagnosis, only
ubsequent hospitalizations were analyzed. In-hospital
ransfers or between the Olmsted Medical Center and
ayo Clinic hospitals were considered a single hospitaliza-
ion. Hospital admissions within 1 day of the previous
ischarge were reviewed to determine whether they repre-
ented separate hospitalizations.
The principal diagnosis for each hospitalization was
ssessed using the primary ICD-9 code. This code, assigned
y trained personnel after discharge, reflects the main reason
or admission. Subsequent ICD-9 codes were not examined,
s there is discretion in their number and order. The
rimary reason for hospitalization was divided into 1 of 3
ategories (17,18): HF (ICD-9 codes, see the Online
ppendix), other cardiovascular (ICD-9 390 through 459
xcept those used to define HF), or noncardiovascular (all
ther ICD-9 codes). Noncardiovascular codes were further
rouped by type of problem.
Mortality follow-up occurred via the medical record. In
ddition to deaths noted in clinical care, the Mayo Clinic
egistration office records obituaries and local death notices,
nd death data are obtained from the State of Minnesota
epartment of Vital and Health Statistics quarterly.
tatistical analysis. Baseline patient characteristics are pre-
ented as percentages or mean (SD). Differences in baseline
haracteristics by sex were tested using the chi-square test
or categorical variables or a 2-sample t test for continuous
ariables. The rate of hospitalization was examined by year
f HF diagnosis (1987 through 1991, 1992 through 1996,
997 through 2001, and 2002 through 2006) or by sex and
as determined using the total hospitalizations divided by
he person-years at risk for hospitalization. Differences were
ested using Poisson regression. Trends in the length of stay
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October 27, 2009:1695–702 Hospitalization After Heart Failureccording to year and differences by sex were analyzed using
eneralized linear models; length of stay was log trans-
ormed in analysis. The reason for hospitalization was
xamined overall, by year of HF diagnosis, and by sex.
rends in the reason for hospitalization by year of HF
iagnosis were examined using the Mantel-Haenszel chi-
quare test; differences by sex were tested using the chi-
quare test. Andersen-Gill models (19) were used to identify
he independent predictors of hospitalization. This tech-
ique allows all hospitalizations to be analyzed, in contrast
o Cox modeling used in most studies that only consider the
rst hospitalization. Patients were censored at death or last
ollow-up. Missing data was 2% per variable with the
xception of EF (n  281 missing). Multiple imputation
as used to impute missing values. Five datasets were
reated and analyzed, with results combined using Rubin’s
ules (20). Analyses were performed using SAS version 8.2
SAS Institute Inc., Cary, North Carolina) and S-PLUS
ersion 8 (TIBCO Software Inc., Palo Alto, California). A
value of 0.05 was used as the level of significance.
esults
tudy population. A total of 1,091 patients with incident
F were identified from 1987 through 2006. Fourteen
atients, hospitalized at initial HF diagnosis, died during
hat hospitalization and were excluded from analysis as they
ere ineligible for subsequent hospitalizations, resulting in a
tudy population of 1,077. The baseline characteristics are
aseline Patient CharacteristicsTable 1 Baseline Patient Characteristics
Missing Overall (n  1,
Age (yrs) — 76.8 (12.7)
EF (%) 281 46.3 (17.5)
Inpatient at HF diagnosis — 56.0
Year of HF diagnosis
1987–1991 — 20.8
1992–1996 — 26.1
1997–2001 — 26.5
2002–2006 — 26.6
Risk factors and comorbidities
Hypertension — 74.6
Current smoker 12 14.2
Hyperlipidemia — 44.3
Diabetes mellitus 2 21.1
Body mass index (kg/m2) 17 29.4 (10.1)
Prior MI 4 20.1
COPD — 23.5
Cerebrovascular disease 1 24.6
Peripheral vascular disease — 22.0
Charlson index 3 5 43.0
Laboratory data
Anemia 15 43.9
Creatinine clearance (ml/min) 10 58.2 (21.6)
ll values are % or mean (SD).
COPD  chronic obstructive pulmonary disease; EF  ejection fraction; HF  heart failure; MI hown in Table 1. Compared with patients with reduced EF50%), patients with preserved EF (50%) were slightly
lder (77.8 vs. 77.3 years for preserved vs. reduced EF,
espectively; p  0.001) and more likely female (58.6% vs.
6.8% for preserved vs. reduced EF, respectively; p 
.001). The proportion of patients with a Charlson comor-
idity index3 increased over the study period (p 0.001).
ospitalizations after HF diagnosis. A total of 4,359
ospitalizations occurred during a mean (SD) follow-up of
.7 (3.9) years. At study end, 798 (74.1%) patients had died.
ospitalizations after HF diagnosis were common (Fig. 1)
nd ranged from 0 to 42 (median: 3) per person. A similar
Men (n  495) Women (n  582) p Value
73.3 (12.8) 79.8 (11.8) 0.001
41.6 (15.9) 50.6 (17.8) 0.001
55.6 56.3 0.82
21.0 20.6 0.70
26.3 25.9 —
27.7 25.4 —
25.1 28.0 —
65.9 82.0 0.001
19.1 10.1 0.001
49.1 40.2 0.003
23.7 18.9 0.06
30.0 (10.2) 28.8 (10.0) 0.001
24.9 16.0 0.001
26.9 20.6 0.02
24.0 25.1 0.68
26.5 18.2 0.001
46.1 40.3 0.06
45.0 42.9 0.50
60.9 (22.8) 56.0 (20.2) 0.001
ardial infarction.
Figure 1 Number of Hospitalizations
Per Person After HF Diagnosis
The number of hospitalizations per individual from heart failure (HF) diagnosis
until death or last follow-up are shown.077)
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Hospitalization After Heart Failure October 27, 2009:1695–702istribution was observed among those who died, where
ospitalizations ranged from 0 to 42 (median: 4) per person,
ndicative of lifetime hospitalizations after HF diagnosis. A
otal of 895 (83.1%) patients were hospitalized at least once,
nd 721 (66.9%), 577 (53.6%), and 459 (42.6%) were
ospitalized 2, 3, and 4 times, respectively. Both HF
nd non-HF hospitalizations increased in the months prior
o death (Fig. 2).
The mean rate of hospitalization was 86.6 per 100
erson-years (95% confidence interval [CI]: 84.0 to 89.2).
hus, for each year after HF diagnosis, patients were
ospitalized 0.87 times on average, or nearly once per year.
en were hospitalized more frequently, with 92.0 hospi-
alizations per 100 person-years (95% CI: 88.2 to 95.9)
ompared with 81.8 hospitalizations per 100 person-years
95% CI: 78.4 to 85.3) for women (p  0.001). The rate of
ospitalization after HF did not change over time.
The median length of stay per hospitalization was 5
25th, 75th percentile: 3, 7) days. The length of stay
eclined over the study period, with median values of 6, 5,
, and 4 days for hospitalizations from 1987 through 1991,
992 through 1996, 1997 through 2001, and 2002 through
007, respectively (p for trend 0.001). Length of stay was
Figure 2 Number of Hospitalizations
in the Year Prior to Death
The number of heart failure (HF) and non-HF hospitalizations in the year before
death among patients who died during follow-up (n  798) are shown.
rimary Cause of Hospitalization According to Year of Diagnosis anTable 2 Primary Cause of Hospitalization According to Year of
Type o
HF Other CV
Overall 713 (16.5) 936 (21.6)
Year of HF diagnosis
1987–1991 210 (19.4) 200 (18.5)
1992–1996 225 (16.8) 299 (22.3)
1997–2001 184 (15.7) 288 (24.6)
2002–2006 94 (12.8) 149 (20.3)
Sex
Male 359 (16.7) 492 (22.9)
Female 354 (16.3) 444 (20.4)V  cardiovascular; HF  heart failure.imilar among men and women (median: 5 days vs. 5 days,
 0.40).
rimary reason for hospitalization. ICD-9 codes were
issing in 31 of 4,359 (1%) hospitalizations, leaving
,328 included in the reason for hospitalization analysis
Table 2). HF was the primary reason for hospitalization
n 713 (16.5%) hospitalizations, whereas 936 (21.6%)
ere due to other cardiovascular causes. Most hospital-
zations (n  2,679, 61.9%) were due to noncardiovas-
ular causes. The primary cause of hospitalization did not
iffer by sex (p  0.106), but changed over time (p 
.001), with a decrease in the proportion of hospitaliza-
ions due to HF noted. The most common reasons for
ther cardiovascular hospitalizations were ischemic heart
isease (ICD-9 410 through 414: 299 of 936 hospital-
zations, 31.9%) and arrhythmias (ICD-9 427: 249 of 936
ospitalizations, 26.6%).
Reasons that accounted for 1% of noncardiovascular
ospitalizations are shown in Table 3. Respiratory tract
nfections, chronic lung disease, and other respiratory symp-
oms accounted for a large proportion of noncardiovascular
ospitalizations (30.4%). Bone and joint diseases accounted
or an additional 11.0%. Comorbidities frequent in HF
atients, including kidney disease, psychiatric disease, and
iabetes mellitus, were additional common reasons for
ospitalization.
F hospitalizations. Although only 713 (16.5%) hospital-
zations were due to HF, these were clustered among a
raction of the cohort, with just 348 of 1,077 (32.3%)
atients ever having an HF hospitalization after diagnosis
hospitalization at the time of incident HF diagnosis ex-
luded). Overall, 39.8% of patients with EF 50% were
ospitalized for HF at least once compared with 34.0% of
atients with EF 50% (p  0.069). Among the 348 with
n HF hospitalization, the number of HF hospitalizations
anged from 1 to 21, and 205 (58.9%) had 1, 67 (19.3%) had
, and 76 (21.8%) had 3 or more. The incident HF patients
ith 2 or more HF hospitalizations (n 143) accounted for
he majority of HF hospitalizations (508 of 713, 71.2%).
hey were younger than the rest of the cohort (mean age
4.0 years vs. 77.2 years, p  0.001), had higher body mass
xosis and Sex
italization, n (%)
p ValueNon-CV Total Hospitalizations
2,679 (61.9) 4,328
0.001
670 (62.0) 1,080
819 (61.0) 1,343
699 (59.7) 1,171
491 (66.9) 734
0.11
1,302 (60.5) 2,153
1,377 (63.3) 2,175d SeDiagn
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October 27, 2009:1695–702 Hospitalization After Heart Failurendex (mean 31.1 kg/m2 vs. 29.1 kg/m2, p  0.004), more
requently had diabetes (29.4% vs. 19.8%, p  0.009), and
ess frequently had COPD (16.8% vs. 24.5%, p  0.04).
ther baseline characteristics were similar.
The length of stay for HF hospitalizations was similar to
on-HF hospitalizations (median 4 [25th, 75th percentile:
, 7] vs. median 5 [25th, 75th percentile: 3, 8] days,
espectively; p  0.064), and decreased over time with
edian values of 7, 5, 4, and 4 days for hospitalizations from
987 through 1991, 1992 through 1996, 1997 through
001, and 2002 through 2007, respectively (p for trend
0.001).
isk factors for hospitalization after HF diagnosis. The
nivariate predictors of hospitalization are shown in Figure
. Age, hypertension, diabetes, COPD, peripheral vascular
isease, cerebrovascular disease, anemia, and decreased renal
unction were each univariately associated with an increased
isk of hospitalization. In multivariable analysis, male sex,
iabetes, COPD, anemia, and a creatinine clearance 30
l/min were independent predictors of hospitalization (Fig.
). Ancillary analysis examining “time to first” hospitaliza-
ion after HF diagnosis using standard Cox modeling
ielded similar results. In contrast to all-cause hospitaliza-
ion, the independent predictors of a first HF hospitaliza-
ion after diagnosis included diabetes (hazard ratio [HR]:
rimary Cause of Noncardiovascular Hospitalizations Based on ICDTable 3 Primary Cause of Noncardiovascular Hospitalizations B
Primary Cause* ICD
Respiratory
Respiratory tract infections 465–490, 507
Chronic lung disease 491–496, 511
Respiratory symptoms, other 786
Musculoskeletal
Bone disorders/fracture 730–736, 802
Joint disorders/osteoarthritis 710–726
Gastrointestinal
Intestinal disorders 555–569, 787
Esophagus/stomach/duodenum disorders 530–537
Liver, gallbladder, pancreas disorders 571–577
Gastrointestinal bleed 578
Kidney/ureter/bladder disorder including acute renal failure 580–599, 788
Cancer/benign tumors 143–238
Procedural/other medical complications 996–999
General symptoms 780, 799
Fluid and electrolyte disorders 276
Nonrespiratory infections
Cellulitis/skin infections 681–686
Sepsis/other infection 003, 008, 035
Diabetes mellitus 250
Psychiatric disease 290–312
Dermatologic disorders and skin ulcers 692–707, 782
Hernias 550–553
Noncardiovascular causes of hospitalization constituting 1% of the total hospitalizations are sh
or purposes of reporting.
CV  cardiovascular; ICD-9  International Classification of Diseases-9th Revision..56, 95% CI: 1.20 to 2.02) and creatinine clearance 30 to s60 ml/min (HR: 1.42, 95% CI: 1.13 to 1.78). COPD was
ssociated with a nonsignificant increase in risk of HF
ospitalization (HR: 1.29, 95% CI: 0.99 to 1.68).
iscussion
n this community HF cohort, patients were hospitalized
requently after incident HF diagnosis over the course of their
ifetime. The majority of hospitalizations were due to noncar-
iovascular causes, the most common being respiratory etiol-
gies. Although HF was the primary reason for only 16.5% of
ospitalizations, these were experienced by a small number of
atients who often had repeated HF admissions. The inde-
endent risk factors for all-cause hospitalization were male sex,
OPD, diabetes, anemia, and renal dysfunction.
ommunity burden of hospitalizations among incident
F patients. The number of HF hospitalizations has in-
reased dramatically over the past several decades (1,21,22).
ata from the National Hospital Discharge Survey suggests
hat hospitalizations with anymention of HF have tripled from
.3 million in 1979 to 3.9 million in 2004 (21), and HF
ospitalizations have become a major public health burden.
ommunity studies indicate that although the incidence of HF
as remained stable over time, survival has improved, leading
o an increase in the prevalence of HF in the U.S. (2,3), which
deson ICD-9 Codes
des† n
% of Total
Hospitalizations
(n  4,328)
% of Non-CV
Hospitalizations
(n  2,679)
011 398 9.2% 14.9%
516, 518, 519 254 5.9% 9.5%
162 3.7% 6.0%
188 4.3% 7.0%
106 2.4% 4.0%
184 4.3% 6.9%
61 1.4% 2.3%
52 1.2% 1.9%
49 1.1% 1.8%
143 3.3% 5.3%
111 2.6% 4.1%
101 2.3% 3.8%
97 2.2% 3.6%
73 1.7% 2.7%
70 1.6% 2.6%
078, 079, 112 69 1.6% 2.6%
69 1.6% 2.6%
67 1.5% 2.5%
58 1.3% 2.2%
44 1.0% 1.6%
D-9 codes were categorized according to first 3 digits (i.e., 465.XX) and grouped by problem type-9 Coased
-9 Co
, 513,
, 515,
–824
, 789
–053,
own. †ICuggests that the increase in HF hospitalizations reflects, in
p
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Hospitalization After Heart Failure October 27, 2009:1695–702art, the larger population of patients. Yet, little is known
bout the burden of hospitalization among HF patients,
ncluding the rate and cumulative number of hospitalizations
Figure 3 Univariate Predictors of Hospitalization After HF Diagn
The unadjusted hazard ratios (95% confidence intervals [CIs]) for risk of hospitaliz
BMI  body mass index; COPD  chronic obstructive pulmonary disease; EF  eje
Figure 4 Multivariable Predictors of Hospitalization After HF Di
The adjusted hazard ratios (95% CIs) for risk of hospitalization using Andersen-Gill
modeling are shown. All variables shown were included in the model. Abbreviationer patient that occur after HF diagnosis and whether tempo-
al changes have occurred. Studies have suggested that read-
ission rates are high in patients with a prior HF admission
sing Andersen-Gill modeling are shown.
fraction; HF  heart failure; MI  myocardial infarction.
sis
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October 27, 2009:1695–702 Hospitalization After Heart Failure8,23,24); however, these data may lack generalizability as they
re limited to patients with an HF hospitalization, itself a poor
rognostic sign (9,10).
The present study brings important new knowledge by
xamining hospitalizations over the course of a lifetime after
ncident HF diagnosis, thereby enabling us to report on the
omprehensive experience of patients living with HF in the
ommunity. Our findings indicate that hospitalizations are
ommon after HF diagnosis, occurring nearly once per year.
he majority (83%) of HF patients experienced at least 1
ospitalization after diagnosis, and multiple hospitalizations
ere common. Further, the rate of admissions for individ-
als diagnosed with HF showed no signs of abatement in
ecent years. These findings are particularly striking, given
he extensive efforts to reduce hospitalizations in HF (25),
nd raise the question of the cause of HF hospitalizations.
rimary reason for hospitalization. Little is known about
he etiology of hospitalizations among HF patients. Fang et
l. (21) examined hospitalizations from the National Hos-
ital Discharge Survey from 1979 through 2004. They
ound that the proportion of hospitalizations with HF as a
rst-listed diagnosis remained at approximately 30% over
he study period. However, there was a decline in the
roportion of admissions due to coronary or other cardio-
ascular diseases, and an increase in the proportion due to
oncardiovascular diseases. Curtis et al. (8) examined hos-
ital readmission rates among Medicare beneficiaries hos-
italized with HF from 2001 through 2005 and found that
pproximately 27% of readmissions were due to HF. This
nalysis did not include patients without a prior HF
ospitalization and only examined the first readmission, and
hus cannot provide information on the total burden of
ospitalizations. To date, the cause of hospitalization
mong community HF patients, and potential temporal
hanges, remain unclear.
The present analysis indicates that HF is the primary
ause of hospitalization only 16.5% of the time. However,
mong patients with at least 1 HF hospitalization, repeat
F admissions are common, and a small proportion of HF
atients account for the majority of HF admissions. Impor-
antly, most hospitalizations were due to noncardiovascular
auses (62%), and HF hospitalizations have decreased over
ime. There are several potential explanations for these
ndings. First, the prevalence of HF patients with preserved
F may have increased (26), and these patients often have
ore comorbidities that could lead to non-HF hospitaliza-
ions. Although patients with reduced EF experienced HF
dmissions more commonly than preserved-EF patients
40% vs. 34%, respectively), the difference was not signifi-
ant. Second, the shift to non-HF causes of hospitalizations
ay be attributable to the observed increase in the burden of
omorbidities among HF patients over time. Further,
hanges in diagnosis or coding patterns resulting in a shift
rom HF to other causes could not be excluded. The
mplications of these findings are 2-fold: first, community
F patients are elderly and have a high burden of comor- didities, which may necessitate hospitalization even if HF is
ell-treated, and second, addressing non-HF comorbidities
ay prevent hospitalizations in HF patients.
isk factors for hospitalization after HF diagnosis. Re-
ent public health efforts have aimed to decrease hospital-
zations in HF. Certainly, HF admission has emerged as a
isk factor for hospital readmission (8). However, despite
ultiple studies, no consistent predictors of readmission
mong patients with HF have emerged (4). Though there
re several studies evaluating models of readmission predic-
ors after an HF admission (8,11,27,28), they have limited
isk prediction to patients with a prior HF admission, have
ad short follow-up periods, and have restricted analyses to
ime-to-first hospitalization, thereby missing the cumulative
urden of hospitalizations that may occur over the course of
lifetime after HF diagnosis. To the best of our knowledge,
o studies have examined predictors of admission using
ncident-validated HF patients followed for a prolonged
ime period or used modeling techniques to account for
epeated hospitalizations after HF diagnosis. As HF is a
hronic disease characterized by periodic exacerbations of-
en leading to multiple hospitalizations, analyzing only the
rst rehospitalization excludes information from subsequent
ospitalizations. Herein, independent risk factors for all-
ause admissions after HF diagnosis are male sex, diabetes
ellitus, COPD, anemia, and reduced creatinine clearance
t HF diagnosis. Detection of these factors among newly
iagnosed HF patients may help in identifying those at
ighest risk for multiple admissions and for whom more
ntense care is needed. The fact that most hospitalizations
mong HF patients are due to non-HF causes underscores
he urgent need to determine whether targeting comorbidi-
ies could lead to a decrease in hospitalizations.
tudy limitations. First, although all hospitalizations in
he community were captured in our study, hospitalizations
utside of the county were not included. However, as the
ounty is relatively isolated, hospitalizations outside of the
ounty are likely rare. Second, the use of ICD-9 codes to
dentify the cause of hospitalization may lead to some
isclassification. However, ICD-9 codes for HF have not
hanged over the study period, and methods for determin-
ng primary ICD-9 codes at Mayo Clinic have remained
onstant and thus should not bias examination of secular
rends. Whether the burden of hospitalizations observed in
F patients differs from the general elderly population was
ot examined, although patients admitted with HF have
een demonstrated to have higher readmission rates than
ther diagnoses in the Medicare population (29). We
annot exclude that unmeasured characteristics such as
edication adherence and clinical care, which were not
valuated, may impact hospitalizations. Further, an assump-
ion of the Andersen-Gill model is that all hospitalizations
ave a common baseline hazard function. There is no
linical indication that this assumption does not hold.
astly, although Olmsted County is becoming increasingly
iverse, the population remains largely Caucasian, and hospi-
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Hospitalization After Heart Failure October 27, 2009:1695–702alizations after HF diagnosis may differ in other racial and
thnic groups. However, our study has several important
trengths, including the use of a validated, incident, commu-
ity HF population followed for a prolonged period of time,
ith the ability to capture all subsequent hospitalizations,
hereby allowing us to assess the burden and risk factors for
ospitalization after HF diagnosis.
onclusions
s the costs of medical care in the U.S. continue to rise,
ecreasing hospitalizations among patients with HF is
ritically important. Our findings indicate that hospitaliza-
ions are common, occurring nearly once per year after
iagnosis. However, the majority are due to noncardiovas-
ular causes, with HF hospitalizations experienced by only
ne-third of all HF patients. The relationship between
omorbidities and increased hospitalization risk, coupled
ith a shift toward non-HF–related causes, indicate that
omorbidities play a central and increasing role in hospital-
zations in patients with HF. These data have important
mplications for preventive efforts to reduce the burden of
ospitalization among patients with HF. Indeed, to be
ffective, strategies aiming to reduce hospitalization must
nclude the identification and management of comorbid
onditions in addition to addressing HF manifestations.
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APPENDIX
or a table on the heart failure ICD-9 codes,
lease see the online version of this article.
